mergers & acquisitions
Precision for Medicine's QuartzBio Acquires Genomic Data Analytics Firm SolveBio
QuartzBio expects SolveBio's genomics and clinical data analytics technology to accelerate biomarker discovery in pursuit of precision therapies.
Inscripta Acquires Infinome Biosciences, Sestina Bio
The acquisitions suggest that Inscripta has shifted its focus to biomanufacturing following dozens of layoffs across two site closures in December.
Agbio Gene Editing Firm Cibus to Merge With Plant Synbio Company Calyxt
The newly merged company will retain the Cibus name and trade on the Nasdaq Capital Market, where Calyxt is currently listed.
Pierian, Seven Bridges, UgenTec Acquired, Merged to Become Velsera
The three firms were acquired by investment fund Summa Equity and merged to form a new Boston-headquartered company.
Scipher Medicine Buys Software Firm CrossBridge
Precision immunology firm Scipher said the acquisition of Philadelphia-based CrossBridge is intended to strengthen its data management and analytics capabilities.